This review provides a comprehensive overview of oral immunosuppressive drugs and corticosteroids used in heart transplant recipients, detailing their pharmacology, dosing, and adverse effects.
Answers are grounded in this paper and cite their sources.
Offers a reference for immunosuppression regimens in heart transplant recipients; leaves open needs for updated outcome trials.
art I of this series describes the mechanisms and types of rejection and the intravenous immunosuppressive drugs commonly used for induction or antirejection therapy.In this article, we review the commonly used oral immunosuppressive drugs.Intravenous corticosteroid methylprednisolone is included in the discussion of corticosteroids.Table 1 gives trade names, pharmacology, necessary adjustments for renal or hepatic dysfunction, and dosing and general monitoring guidelines for drugs described in this section.Table 2 lists the major adverse effects of immunosuppressive drugs described in Parts I and II of this review and provides an estimate of their relative frequency. Corticosteroids (Steroids)Steroids, among the first immunosuppressive agents used in clinical transplantation, have remained an important component of induction, maintenance, and rejection regimens.
No takes yet. Share an insight, caveat, or question.
Lindenfeld et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: